← Back to Clinical Trials
Recruiting NCT07248046

Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Fertility
Sponsor Bruyère Health Research Institute.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex FEMALE
Min Age 16 Years
Max Age 45 Years
Start Date 2026-01-15
Completion 2026-09-15
Interventions
Premom App-Assisted Fertility Tracking

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.

Eligibility Criteria

Inclusion Criteria: * Female, aged 16 to 45 * Natural menstrual cycles equal or less than 35 days * Off hormonal contraception for more than 3 months * Current user of the Premom App * Willing to track cervical mucus, LH, PDG, and BBT for 3 full cycles * Lives within 50 km of study site in the Ottawa region * Able to provide informed consent Exclusion Criteria: * Pregnant or breastfeeding * Current hormonal therapy or contraception * Known anovulatory disorders, e.g., Polycystic Ovary Syndrome, hypothalamic amenorrhea. * Very irregular or absent cycles * Not using the Premom App * Unable or unwilling to complete tracking or provide consent

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}